Publicaciones (60) Publicaciones de MARÍA DEL CONSUELO MODESTO CABALLERO

2022

  1. Intravenous iron treatment-induced hypophosphatemia

    Medicina Clinica

  2. Transient migratory osteoporosis

    Medicina Clinica, Vol. 158, Núm. 3, pp. 147

2021

  1. Clinical remission and subsequent relapse in patients with juvenile idiopathic arthritis: predictive factors according to therapeutic approach

    Pediatric Rheumatology, Vol. 19, Núm. 1

2019

  1. American College of Rheumatology Provisional Criteria for Clinically Relevant Improvement in Children and Adolescents With Childhood-Onset Systemic Lupus Erythematosus

    Arthritis Care and Research, Vol. 71, Núm. 5, pp. 579-590

  2. Anti-IL6-Receptor Tocilizumab in Refractory and Noninfectious Uveitic Cystoid Macular Edema: Multicenter Study of 25 Patients

    American Journal of Ophthalmology, Vol. 200, pp. 85-94

  3. Biallelic loss-of-function LACC1/FAMIN Mutations Presenting as Rheumatoid Factor-Negative Polyarticular Juvenile Idiopathic Arthritis

    Scientific Reports, Vol. 9, Núm. 1

  4. Clinical characteristics and genetic analyses of 187 patients with undefined autoinflammatory diseases

    Annals of the Rheumatic Diseases, Vol. 78, Núm. 10, pp. 1405-1411

  5. Síndrome d’activació macrofàgica com a forma de debut d’una artritis idiopàtica juvenil sistèmica

    Pediatria catalana: butlletí de la Societat Catalana de Pediatria, Vol. 79, Núm. 3, pp. 89-93

  6. Unexpected relevant role of gene mosaicism in patients with primary immunodeficiency diseases

    Journal of Allergy and Clinical Immunology, Vol. 143, Núm. 1, pp. 359-368

  7. Valoración inicial del paciente con sospecha de enfermedad reumática

    Manual de pediatría (Ergon), pp. 1345-1348

2018

  1. Blau Syndrome–Associated Uveitis: Preliminary Results From an International Prospective Interventional Case Series

    American Journal of Ophthalmology, Vol. 187, pp. 158-166

  2. S100A12 and S100A8/9 proteins are biomarkers of articular disease activity in Blau syndrome

    Rheumatology (United Kingdom), Vol. 57, Núm. 7, pp. 1299-1304

2017

  1. Anti–Interleukin-6 Receptor Tocilizumab for Severe Juvenile Idiopathic Arthritis–Associated Uveitis Refractory to Anti–Tumor Necrosis Factor Therapy: A Multicenter Study of Twenty-Five Patients

    Arthritis and Rheumatology, Vol. 69, Núm. 3, pp. 668-675

  2. Novel evidences of atypical manifestations in cryopyrin-associated periodic syndromes

    Clinical and Experimental Rheumatology, Vol. 35, pp. S27-S31

  3. Preliminary Definitions for the Sonographic Features of Synovitis in Children

    Arthritis Care and Research, Vol. 69, Núm. 8, pp. 1217-1223

  4. Subcutaneous tocilizumab may be less effective than intravenous tocilizumab in the treatment of juvenile idiopathic arthritis-Associated uveitis

    Journal of Rheumatology

2016

  1. Efficacy of the Janus kinase 1/2 inhibitor ruxolitinib in the treatment of vasculopathy associated with TMEM173-activating mutations in 3 children

    Journal of Allergy and Clinical Immunology, Vol. 138, Núm. 6, pp. 1752-1755

  2. The Phenotype and Genotype of Mevalonate Kinase Deficiency: A Series of 114 Cases From the Eurofever Registry

    Arthritis and Rheumatology, Vol. 68, Núm. 11, pp. 2795-2805

2015

  1. Clinical and genetic features of Spanish patients with Mevalonate kinase deficiency

    Pediatric Rheumatology, Vol. 13, Núm. 1

  2. Consensus of the Spanish society of pediatric rheumatology for transition management from pediatric to adult care in rheumatic patients with childhood onset

    Rheumatology International, Vol. 35, Núm. 10, pp. 1615-1624